Although TNF-α blockade is a very effective therapy for psoriasis, not all patients achieve a favorable outcome. The association between IL-6 and psoriasis has been investigated but no papers have focused on the pharmacogenetics of IL-6.
DI RENZO, L., Bianchi, A., Saraceno, R., Calabrese, V., Cornelius, C., Iacopino, L., et al. (2012). -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers. PHARMACOGENETICS AND GENOMICS, 22(2), 134-142 [10.1097/FPC.0b013e32834e5e7b].
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers
DI RENZO, LAURA;SARACENO, ROSITA;IACOPINO, LEONARDO;CHIMENTI, SERGIO;DE LORENZO, ANTONINO
2012-02-01
Abstract
Although TNF-α blockade is a very effective therapy for psoriasis, not all patients achieve a favorable outcome. The association between IL-6 and psoriasis has been investigated but no papers have focused on the pharmacogenetics of IL-6.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
45 articolo-2012-PHARMACOGENETIC-GENOMICS PSO.pdf
solo utenti autorizzati
Descrizione: articolo principale
Licenza:
Copyright dell'editore
Dimensione
296.27 kB
Formato
Adobe PDF
|
296.27 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
